Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willibald Hochholzer

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
British Journal of Clinical Pharmacology|August 29, 2013
Genetics of platelet inhibitor treatmentDietmar Trenk, Willibald Hochholzer
The New England Journal of Medicine|January 9, 2020
Axillary Artery Occlusion after TAVRAlexander Kille, Willibald Hochholzer
Current Atherosclerosis Reports|December 18, 2012
Does it make sense to combine statins with other lipid-altering agents following AIM-HIGH, SHARP and ACCORD?Willibald Hochholzer, Robert P Giugliano
Journal of the American College of Cardiology|October 29, 2011
On-clopidogrel platelet reactivity: a target in sight?Stephen D Wiviott, Willibald Hochholzer
European Journal of Preventive Cardiology|November 28, 2019
How to reduce risk in secondary prevention: First of all address the basics!Willibald Hochholzer, Christian M Valina
Deutsche Medizinische Wochenschrift (1946)|June 3, 2016
[The new 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]Willibald Hochholzer, Franz-Josef Neumann
Therapeutic Advances in Cardiovascular Disease|April 20, 2010
Lipid lowering goals: back to nature?Willibald Hochholzer, Robert P Giugliano
International Journal of Cardiology|January 7, 2021
Antiplatelet therapy for STEMI: Hit it hard and early?Willibald Hochholzer, Christian M Valina
JAMA|October 4, 2012
Influence of smoking on treatment with clopidogrelDirk Sibbing, Willibald Hochholzer, Adnan Kastrati
Journal of the American College of Cardiology|January 7, 2017
Reply: Platelet Reactivity: Journey to the End of the NightChristian Wilhelm Stratz, Franz-Josef Neumann, Willibald Hochholzer
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
British Journal of Clinical Pharmacology|August 29, 2013
Genetics of platelet inhibitor treatmentDietmar Trenk, Willibald Hochholzer
The New England Journal of Medicine|January 9, 2020
Axillary Artery Occlusion after TAVRAlexander Kille, Willibald Hochholzer
Current Atherosclerosis Reports|December 18, 2012
Does it make sense to combine statins with other lipid-altering agents following AIM-HIGH, SHARP and ACCORD?Willibald Hochholzer, Robert P Giugliano
Journal of the American College of Cardiology|October 29, 2011
On-clopidogrel platelet reactivity: a target in sight?Stephen D Wiviott, Willibald Hochholzer
European Journal of Preventive Cardiology|November 28, 2019
How to reduce risk in secondary prevention: First of all address the basics!Willibald Hochholzer, Christian M Valina
Deutsche Medizinische Wochenschrift (1946)|June 3, 2016
[The new 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]Willibald Hochholzer, Franz-Josef Neumann
Therapeutic Advances in Cardiovascular Disease|April 20, 2010
Lipid lowering goals: back to nature?Willibald Hochholzer, Robert P Giugliano
International Journal of Cardiology|January 7, 2021
Antiplatelet therapy for STEMI: Hit it hard and early?Willibald Hochholzer, Christian M Valina
JAMA|October 4, 2012
Influence of smoking on treatment with clopidogrelDirk Sibbing, Willibald Hochholzer, Adnan Kastrati
Journal of the American College of Cardiology|January 7, 2017
Reply: Platelet Reactivity: Journey to the End of the NightChristian Wilhelm Stratz, Franz-Josef Neumann, Willibald Hochholzer
Pageof 12